Azathioprine and diffuse alveolar haemorrhage: the pharmacogenetics of thiopurine methyltransferase

Perri D., Cole D. E. C., Friedman O., Piliotis E., Mintz S., Adhikari N. K. J.

Source: Eur Respir J 2007; 30: 1014-1017
Journal Issue: November
Disease area: Interstitial lung diseases

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Perri D., Cole D. E. C., Friedman O., Piliotis E., Mintz S., Adhikari N. K. J.. Azathioprine and diffuse alveolar haemorrhage: the pharmacogenetics of thiopurine methyltransferase. Eur Respir J 2007; 30: 1014-1017

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.

Related content which might interest you:
TNF-α polymorphism as a prognostic marker for MTX efficacy in progressive pulmonary sarcoidosis
Source: International Congress 2016 – Sarcoidosis
Year: 2016

Association of diffuse alveolar hemorrhage with VKORC1, CYP2C9, and CYP2C19 polymorphisms
Source: Annual Congress 2010 - Rare diffuse lung diseases
Year: 2010

The associations of polymorphism C3435T multidrug resistance gene (MDR1) and regimen of inhaled glucocorticosteroid therapy in bronchial asthma (BA) patients
Source: Annual Congress 2008 - Recent advances in the treatment and pathogenesis of asthma
Year: 2008

Therapeutic options for sarcoidosis: old and new
Source: Annual Congress 2005 - PG15 - Therapeutic options for interstitial lung diseases in 2005
Year: 2005

Idiopathic pulmonary haemosiderosis revisited
Source: Eur Respir J 2004; 24: 162-169
Year: 2004

Association between N-acetyltransferase 2 polymorphism and antituberculosis drug-induced liver injury risk: a meta-analysis
Source: International Congress 2017 – Human susceptibility to tuberculosis
Year: 2017

Valproate–doxorubicin: promising therapy for progressing mesothelioma. A phase II study
Source: Eur Respir J 2011; 37: 129-135
Year: 2011

Pulmonary toxicity with mefloquine
Source: Eur Respir J 2001; 18: 890-892
Year: 2001

The new approaches to the oral corticosteroid dosage decrease in patients with severe steroid-resistant bronchial asthma
Source: Annual Congress 2005 - Improving asthma control in the harder-to-reach population
Year: 2005

Azathioprine and low-dose prednisone in chronic pulmonary sarcoidosis
Source: Eur Respir J 2005; 26: Suppl. 49, 268s
Year: 2005

Cytochrome CYP2C9 and vitamin K epoxide reductase gene polymorphisms in patients with pulmonary embolism treated with warfarin
Source: Annual Congress 2007 - The role of gene polymorphisms in pulmonary disease susceptibility
Year: 2007

Anti-inflammatory effects of high-dose inhaled fluticasone versus oral prednisone in asthma exacerbations
Source: Eur Respir J 2007; 30: 1143-1149
Year: 2007

Beyond corticosteroids: future prospects in the management of inflammation in COPD
Source: Eur Respir Rev 2011; 20: 175-182
Year: 2011

Idiopathic pulmonary fibrosis: efficacy of complex immunosuppressive therapy by cyclophosphamide and corticosteroids
Source: Annual Congress 2009 - Various backgrounds in diffuse parenchymal lung disease
Year: 2009

Source: Annual Congress 2005 - MP15 - Pharmacogenetics
Year: 2005

N-acetyltransferase 2 and CYP2E1 polymorphisms do not increase the risk of antituberculosis drug-induced hepatotoxicity in caucasian population
Source: Annual Congress 2008 - Epidemiological and clinical aspects of tuberculosis control
Year: 2008

Effectiveness and safety of leflunomide for pulmonary and extrapulmonary sarcoidosis
Source: Eur Respir J 2011; 38: 1145-1150
Year: 2011

E-cadherin gene polymorphisms in asthma patients using inhaled corticosteroids
Source: Eur Respir J 2011; 38: 1044-1052
Year: 2011

Single-nucleotide polymorphisms within TOLLIP and the efficacy of inhaled N-acetylcysteine therapy in idiopathic pulmonary fibrosis.
Source: International Congress 2019 – Biomarkers and beyond in idiopathic interstitial pneumonia
Year: 2019

Severe therapy resistant asthma
Source: ISSN=1025-448x, ISBN=1-904097-26-x, page=312
Year: 2003